What is the 13F Pro Quality Score for UNH?

13F Pro ranks UNITEDHEALTH GROUP INC (UNH) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View UNH's current score at https://13fpro.ai/research/UNH (free sign-up required for the full ranking).

Which hedge funds own the most UNH stock?

Based on the most recent Form 13F-HR filings on SEC EDGAR, the largest reported institutional holders of UNH include BlackRock,, VANGUARD CAPITAL MANAGEMENT, STATE STREET. Holdings are reported quarterly within 45 days of quarter-end and updated on https://13fpro.ai/research/UNH as soon as new 13F filings post.

Where does 13F Pro source UNH data?

All UNITEDHEALTH GROUP INC fundamentals and ownership data come directly from SEC EDGAR. UNITEDHEALTH GROUP INC files with the SEC under CIK 731766. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is UNH in?

UNITEDHEALTH GROUP INC (UNH) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

What drives UNH's revenue?

Per UNITEDHEALTH GROUP INC's latest 10-Q filed with the SEC on 2026-05-05, the biggest revenue drivers are: Premiums ($87.6B, +1% YoY); Optum Rx ($35.7B, +2% YoY). Figures are extracted from the filing text and machine-verified against the document. Full breakdown at https://13fpro.ai/research/UNH.

What are UNH's largest expenses?

UNITEDHEALTH GROUP INC's latest 10-Q reports these as the largest expense items: Medical costs ($73.5B, Flat YoY); Operating costs ($15.4B, +13% YoY); Cost of products sold ($12.8B, +3% YoY). Sourced directly from SEC EDGAR filing text for Q1 2026 (quarter ended March 31, 2026).

How often is UNH research updated on 13F Pro?

UNH's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

UNITEDHEALTH GROUP INC(UNH)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →NYSE

Institutional-grade research for retail investors

SEC EDGAR: CIK 731766 UNH stock profile & AI dashboard →

13F Pro Quality Score

66.8/100

Rank #497 of 2,879 stocksTOP 25%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

62.2/100

Profitability

52.6/100

Balance Sheet

74.7/100

Earnings Quality

53.4/100

Free Cash Flow

52.1/100

Institutional Flow

59.0/100

Revenue Scale

99.9/100

Dilution Risk

85.3/100

UNH Stock Analysis & AI Quality Score

AI stock analysis and institutional research for UNITEDHEALTH GROUP INC (UNH), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores UNH at 66.8/100 on a 32-signal composite quality model, placing it at rank #497 of 2,879 stocks — the top 25% of the AI-ranked universe. UNH scores in the top quartile across revenue scale (99.9). Based on the latest XBRL financial filings (Q1 2026), UNITEDHEALTH GROUP INC reports quarterly revenue of $111.7B, net income of $6.3B, an operating margin of 8.1%. Top institutional holders of UNH by reported 13-F value include BlackRock,, VANGUARD CAPITAL MANAGEMENT, STATE STREET, based on the most recent SEC filings. UNH trades on the NYSE exchange and files with the SEC under CIK 731766. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate UNH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for UNITEDHEALTH GROUP INC directly from SEC EDGAR. UNITEDHEALTH GROUP INC's 13F Pro composite quality score has ranged between 8 and 72 since 2021, currently 66.8 — a declining long-term trajectory across 56 quarterly and live scoring snapshots.

✦

Fun facts about UNITEDHEALTH GROUP INC

Quirks, history, and lore behind UNH — the kind of stuff that makes a stock memorable.

1
The Basics
U.S. healthcare company · mega-cap · listed on the NYSE · headquartered in Minnesota.
2
The Numbers
Revenue of roughly $370 billion a year, making it one of the largest companies on earth by sales — yet most Americans couldn't pick its logo out of a lineup.
3
The History
Founded in 1977 by a physician and a hospital administrator, it grew by consolidating managed care plans and eventually became the dominant force in U.S. health insurance.
4
The Secret
It runs two massive businesses under one roof: a health insurance giant and a separate pharmacy-and-data arm that quietly powers prescription benefits for tens of millions of people.
5
The Lore
Its Optum division employs more physicians than any other organization in the U.S., and the company landed in the center of a national conversation after a high-profile executive killing in late 2024.
6
The Giveaway
The largest U.S. health insurer, based in Minnesota, whose three letters on the NYSE have become shorthand for everything Americans love — and love to hate — about health insurance.

▶ Think you know your stocks? Play the Daily Ticker

What's Driving UNH's Business? Latest 10-Q Breakdown

✓ 18/18 datapoints verified

AI-extracted from UNITEDHEALTH GROUP INC's 10-Q filed 2026-05-05 — Q1 2026 (quarter ended March 31, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.

UnitedHealth Group Q1 2026 revenues grew 2% to $111.7B, but operating earnings declined 1% to $9.0B amid elevated medical costs and membership contraction in Medicare Advantage.

Biggest Revenue Drivers

Total revenue: $111.7B+2% YoY

Premiums$87.6B+1% YoY

Driven by pricing trends at UnitedHealthcare, offset by decreased people served through Medicare Advantage, commercial risk-based offerings and Medicaid.

Optum Rx$35.7B+2% YoY

Growth in specialty pharmacy partially offset by decreased script volume due to contraction in people served at UnitedHealthcare; fulfilled 383M adjusted scripts.

Largest Expense Items

Medical costs$73.5BFlat YoY

Expected elevated medical cost trend offset by decreased people served and increased favorable reserve development.

Operating costs$15.4B+13% YoY

Investments in people, process and technology to drive improved consumer and care provider experiences; business mix impacts and restructuring actions.

Cost of products sold$12.8B+3% YoY

Aligned with product revenue growth.

Margins: Medical care ratio improved 90 basis points to 83.9% due to increased favorable reserve development, affordability initiatives and pricing trends, partially offset by elevated medical costs. Operating margin declined 30 basis points to 8.0% as operating cost ratio increased 140 basis points, driven by investments in people, process and technology.

Watch Items from the Filing

UnitedHealthcare served 1.1M fewer people YoY; Medicare Advantage membership declined 8% (690K people) due to funding pressures and benefit design actions; further contraction expected throughout 2026.
Optum Health earnings from operations declined 19% to $1.1B; operating margin fell from 5.7% to 4.7%, driven by continued elevated medical cost trends and value-based care headwinds from Medicare funding reductions.
DOJ legal matter regarding improper risk adjustment submissions remains pending; Special Master recommended summary judgment in company's favor in March 2025, but DOJ filed motion to reject in April 2025; company cannot reasonably estimate outcome.
IRS issued Notices of Proposed Adjustment for 2017-2020 tax years regarding intercompany transfer pricing with foreign subsidiary, seeking to significantly increase taxable income; company believes positions are properly supported and intends to vigorously contest.
Company has entered agreements to acquire healthcare companies totaling approximately $3.0B anticipated capital, majority expected to close in H2 2026, subject to regulatory approval.

AI-extracted and verified against SEC EDGAR filing text. Not investment advice.

Read the full 10-Q on SEC EDGAR →Share on X

Revenue

Q1 2026

$111.7B

Net Income

Q1 2026

$6.3B

Free Cash Flow

Q1 2026

$8.1B

Operating Margin

Q1 2026

8.1%

ROIC

Q1 2026

5.1%

D/E Ratio

Q1 2026

0.75

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+7.7% YoY

$400.28BFY 2024

FY20 $257.14BFY22 $324.16BFY23 $371.62BFY24 $400.28B

Net Income

-35.6% YoY

$14.40BFY 2024

FY20 $15.40BFY22 $20.12BFY23 $22.38BFY24 $14.40B

Operating Income

-0.2% YoY

$32.29BFY 2024

FY20 $22.41BFY22 $28.43BFY23 $32.36BFY24 $32.29B

EPS (Diluted)

-35.0% YoY

$15.51FY 2024

FY20 $16.03FY22 $21.18FY23 $23.86FY24 $15.51

Total Assets

+9.0% YoY

$298.28BFY 2024

FY20 $197.29BFY22 $245.71BFY23 $273.72BFY24 $298.28B

Total Debt

+23.9% YoY

$76.18BFY 2024

FY20 $42.28BFY22 $56.76BFY23 $61.47BFY24 $76.18B

Op. Cash Flow

-16.7% YoY

$24.20BFY 2024

FY20 $22.17BFY22 $26.21BFY23 $29.07BFY24 $24.20B

Metric	FY 2024	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018
Revenue	$400.28B +7.7%	$371.62B +14.6%	$324.16B +26.1%	$257.14B +6.2%	$242.16B +7.0%	$226.25B
Net Income	$14.40B -35.6%	$22.38B +11.2%	$20.12B +30.6%	$15.40B +11.3%	$13.84B +15.5%	$11.99B
Operating Income	$32.29B -0.2%	$32.36B +13.8%	$28.43B +26.9%	$22.41B +13.8%	$19.68B +13.5%	$17.34B
EPS (Diluted)	$15.51 -35.0%	$23.86 +12.7%	$21.18 +32.1%	$16.03 +11.9%	$14.33 +17.6%	$12.19
Total Assets	$298.28B +9.0%	$273.72B +11.4%	$245.71B +24.5%	$197.29B +13.5%	$173.89B +14.2%	$152.22B
Total Debt	$76.18B +23.9%	$61.47B +8.3%	$56.76B +34.2%	$42.28B +7.1%	$39.47B +12.0%	$35.23B
Operating Cash Flow	$24.20B -16.7%	$29.07B +10.9%	$26.21B +18.2%	$22.17B +20.1%	$18.46B +17.5%	$15.71B

AI Insight: UNH Financial Trends

UNH collapsed to near-zero profitability in Q4 2025, but rebounded sharply in Q1 2026 with operating income recovering to $8.99B—signaling either a one-time charge or operational disruption that has since reversed.

• Q4 2025 net income plummeted to $10M from $2.35B in Q3 2025, despite operating income of $380M and revenue of $113.2B.

• Q1 2026 net income rebounded to $6.28B; operating income recovered to $8.99B, highest since Q1 2025 at $9.12B.

• Operating cash flow remained volatile: $1.11B in Q4 2025, then $8.91B in Q1 2026, suggesting timing or working-capital normalization.

⚠ Q4 2025 extraordinary profit collapse (99.6% decline YoY in net income) lacks obvious explanation in revenue/op income—investigate non-operating charges.

⚠ Total debt rose to $81.3B in Q1 2025, highest in the series; currently $77.9B, but leverage ratio warrants monitoring if profitability destabilizes.

AI Insight: UNH Ratio Trends

UNH rebounded sharply in Q1 2026 after a catastrophic Q4 2025, but TTM profitability metrics remain deeply depressed versus 2024 levels.

• Operating margin crashed from 8.3% in Q1 2025 to 0.3% in Q4 2025, then recovered to 8.1% in Q1 2026—signaling acute Q4 disruption, likely resolved.

• Q1 2026 ROE rebounded to 24.2% and ROIC to 19.8%, mirroring Q1 2025 levels, suggesting core operational health has stabilized post-Q4.

• TTM operating margin of 4.7% and ROIC of 10.4% remain 45–50% below Q2–Q4 2024 baseline, despite Q1 2026 recovery.

⚠ Q4 2025 profitability nearly zeroed out (OpMargin 0.3%, NPM 0.0%)—unprecedented in this dataset. Cause and permanence require clarity.

⚠ Debt-to-equity fell to 0.75 in Q1 2026 from 0.79, marking modest deleveraging after spike to 0.81 in Q1 2025.

Get alerted when UNH's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for UNITEDHEALTH GROUP INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of UNH

BlackRock, Inc.
$19.9B73,467,531 sh
VANGUARD CAPITAL MANAGEMENT LLC
$15.9B58,870,777 sh
STATE STREET CORP
$12.3B45,332,186 sh
Capital World Investors
$7.5B27,783,415 sh
VANGUARD PORTFOLIO MANAGEMENT LLC
$6.5B24,036,504 sh
GEODE CAPITAL MANAGEMENT, LLC
$6.1B22,768,695 sh
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
$5.6B20,817,755 sh
Capital Research Global Investors
$4.6B17,112,218 sh
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$4.3B15,920,300 sh
MORGAN STANLEY
$4.0B14,963,569 sh

Fund	Value	Shares
BlackRock, Inc.	$19.9B	73,467,531
VANGUARD CAPITAL MANAGEMENT LLC	$15.9B	58,870,777
STATE STREET CORP	$12.3B	45,332,186
Capital World Investors	$7.5B	27,783,415
VANGUARD PORTFOLIO MANAGEMENT LLC	$6.5B	24,036,504
GEODE CAPITAL MANAGEMENT, LLC	$6.1B	22,768,695
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$5.6B	20,817,755
Capital Research Global Investors	$4.6B	17,112,218
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$4.3B	15,920,300
MORGAN STANLEY	$4.0B	14,963,569

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put UNH on your watchlist

Track score changes the day UNITEDHEALTH GROUP INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is UNH a good stock to buy?

13F Pro's AI-powered analysis of UNITEDHEALTH GROUP INC (UNH) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for UNH are available on the UNH stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own UNH?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling UNH. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of UNITEDHEALTH GROUP INC's investment landscape.